Drawing for KALDI PHARMA

USPTO serial 88170554

KALDI PHARMA

Reviewed by CopyMark Law Group

Reg. 5930209Status 710
Filing date
Status date
Registration date
Dec 10, 2019
Examiner
KEATING, MICHAEL P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KALDI PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey M. Goehring

Jeffrey M. Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, 11th FloorArlington, VA 22203UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the biological, biotechnological, medical, pharmaceutical, and veterinary research; biological preparations for use in the biological, biotechnological, medical, pharmaceutical, and veterinary researchSECTION 8 - CANCELLED—
005Chemical reagents for medical purposesSECTION 8 - CANCELLED—
042Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2026C8..CANCELLED SEC. 8 (6-YR)—
Dec 10, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 25, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 25, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Nov 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 23, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 23, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Sep 20, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 10, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jun 7, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2019ALIEASSIGNED TO LIE—
Mar 11, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 7, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 7, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Mar 7, 2019CNSLSUSPENSION LETTER WRITTEN—
Mar 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2019DOCKASSIGNED TO EXAMINER—
Nov 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance